Syngenta Group, the Chinese-owned seed and pesticide behemoth, has withdrawn its protracted application for a $9 billion initial public offering (IPO) in Shanghai. This surprising turnaround has been seen as a subsequent setback to China’s equity markets, already troubled following Alibaba Group Holding Ltd’s cancellation of the listing of its logistics arm earlier this week.
The initial plans for the IPO were put on hold while the company stated, as per an announcement on its website, that “it will look to restart the listing process, either in China or a different global exchange, when the conditions are right”. Syngenta also declared its intention to seek “alternate sources of funding”.
This development, confirming a reported story by Bloomberg News, underscores some of the challenges faced by Chinese equities, particularly in the current economic climate. Considerations of regulatory risks and the swelling pressures on the tech sector both domestically and abroad have compounded investor worries about a potential slow-down in the world’s second-largest economy.
The company’s decision to withdraw its IPO application is not an isolated incident and follows a series of postponements by other businesses in the past few years. Legal professionals around the world, particularly those concerned with Chinese economy and practice, will be looking on with interest to understand how this develops and what its implications will be for future IPO bids.
More information about these developments can be found here.